GRFS logo

GRFS Grifols, S.A.

NASDAQ Global Select · Drug Manufacturers - General · Healthcare

$8.15
-0.05 (-0.61%)

Grifols, S.A., a Spanish company established in 1940 and headquartered in Barcelona, specializes in the comprehensive process of acquiring, manufacturing, preparing, and distributing therapeutic products, with a primary focus on those derived from plasma. The company operates through several key divisions: Bioscience, Hospital, Diagnostic, and Bio Supplies, among others. The Bioscience division is…

Market Cap: $6.89Bwww.grifols.com

Price

No data yet.

Social Signal Score

57
5d
—
30d
55
2 mentions
—
60d
59
4 mentions
—
90d
57
6 mentions
—
news: 6

Analyst Ratings

8 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 2Sell 2Strong Sell 0

Revenue

$2.04B+112.74%
$958.93M$1.32B$1.68B$2.04B
Mar 2016Sep 2026

Analyst Estimates

FY2025
$0.72
$0.62–$0.82
2 analysts
FY2026
$0.87+21% YoY
$0.80–$0.95
1 analysts
FY2027
$1.07+23% YoY
$0.99–$1.14
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jose Ignacio Abia Buenache
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
25,258
Beta
1.19
Country
ES
Piotroski score
6 / 9 (Middling)
Altman Z-score
1.12
www.grifols.com